搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Carica papaya NAD (P)H-quinone oxidoreductase subunit K, chloroplastic CSB-YP536570DQH
CSB-EP536570DQH
CSB-BP536570DQH
CSB-MP536570DQH
CSB-EP536570DQH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Carica papaya Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta, chloroplastic (accD) CSB-YP536571DQH
CSB-EP536571DQH
CSB-BP536571DQH
CSB-MP536571DQH
CSB-EP536571DQH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Carica papaya Photosystem I reaction center subunit IX (psaJ), partial CSB-YP536572DQH
CSB-EP536572DQH
CSB-BP536572DQH
CSB-MP536572DQH
CSB-EP536572DQH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Carica papaya 30S ribosomal protein S19, chloroplastic (rps19) CSB-YP536573DQH
CSB-EP536573DQH
CSB-BP536573DQH
CSB-MP536573DQH
CSB-EP536573DQH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Carica papaya NAD (P)H-quinone oxidoreductase chain 4, chloroplastic, partial CSB-YP536574DQH
CSB-EP536574DQH
CSB-BP536574DQH
CSB-MP536574DQH
CSB-EP536574DQH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Carica papaya NAD (P)H-quinone oxidoreductase subunit H, chloroplastic CSB-YP536575DQH
CSB-EP536575DQH
CSB-BP536575DQH
CSB-MP536575DQH
CSB-EP536575DQH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Putative peripheral benzodiazepine receptor-related protein (TSPO) CSB-YP536576HU
CSB-EP536576HU
CSB-BP536576HU
CSB-MP536576HU
CSB-EP536576HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Serine--tRNA ligase (serS) CSB-YP536577UBK
CSB-EP536577UBK
CSB-BP536577UBK
CSB-MP536577UBK
CSB-EP536577UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 UvrABC system protein B (uvrB), partial CSB-YP536578UBK
CSB-EP536578UBK
CSB-BP536578UBK
CSB-MP536578UBK
CSB-EP536578UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 30S ribosomal protein S15 (rpsO) CSB-YP536579UBK
CSB-EP536579UBK
CSB-BP536579UBK
CSB-MP536579UBK
CSB-EP536579UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 50S ribosomal protein L21 (rplU) CSB-YP536580UBK
CSB-EP536580UBK
CSB-BP536580UBK
CSB-MP536580UBK
CSB-EP536580UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 30S ribosomal protein S19 (rpsS) CSB-YP536581UBK
CSB-EP536581UBK
CSB-BP536581UBK
CSB-MP536581UBK
CSB-EP536581UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Adenylate kinase (adk) CSB-YP536582UBK
CSB-EP536582UBK
CSB-BP536582UBK
CSB-MP536582UBK
CSB-EP536582UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 50S ribosomal protein L36 (rpmJ) CSB-YP536583UBK
CSB-EP536583UBK
CSB-BP536583UBK
CSB-MP536583UBK
CSB-EP536583UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 tRNA (guanine-N (7)-)-methyltransferase CSB-YP536584UBK
CSB-EP536584UBK
CSB-BP536584UBK
CSB-MP536584UBK
CSB-EP536584UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Probable transcriptional regulatory protein UPA3_0303 (UPA3_0303) CSB-YP536585UBK
CSB-EP536585UBK
CSB-BP536585UBK
CSB-MP536585UBK
CSB-EP536585UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 50S ribosomal protein L32 (rpmF) CSB-YP536586UBK
CSB-EP536586UBK
CSB-BP536586UBK
CSB-MP536586UBK
CSB-EP536586UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Leucine--tRNA ligase (leuS), partial CSB-YP536587UBK
CSB-EP536587UBK
CSB-BP536587UBK
CSB-MP536587UBK
CSB-EP536587UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP536588UBK
CSB-EP536588UBK
CSB-BP536588UBK
CSB-MP536588UBK
CSB-EP536588UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Urease subunit alpha (ureC), partial CSB-YP536589UBK
CSB-EP536589UBK
CSB-BP536589UBK
CSB-MP536589UBK
CSB-EP536589UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>